Cavis Technologies AB’s Post

𝐓𝐡𝐨𝐮𝐠𝐡𝐭 𝐄𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭: What is the use and safety of implanting an atrial lead into primary prevention ICD patients without a pacing indication? Interesting data out of Mass General Brigham and Tufts Medical Center helps explore this, as reported in the attached JAHA piece. 𝐈𝐧 𝐨𝐯𝐞𝐫 𝟏𝟓,𝟎𝟎𝟎 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐢𝐦𝐩𝐥𝐚𝐧𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐚𝐧 𝐈𝐂𝐃 𝐟𝐨𝐫 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐧𝐨 𝐩𝐚𝐜𝐢𝐧𝐠 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝟓𝟓% 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐚 𝐝𝐮𝐚𝐥 𝐜𝐡𝐚𝐦𝐛𝐞𝐫 𝐈𝐂𝐃 Potential Reasons? *Arrhythmia discrimination capabilities *Atrial arrhythmia diagnostic potential (for which the paper suggests the prospect of using a floating atrial dipole) *Potential need for atrial pacing (observed actual number is 3-5%) The dual chamber cohort was significantly associated with a higher rate of in-hospital complications vs. single chamber Given the growing application of Dx/VDD technology (100,000 implants and counting), we believe this data reinforces that platform’s utility…particularly regarding safety, and when applied to AHRE identification for the purposes of OAC administration and #ablation #epeeps #biotronik #atrialfibrillation

More great news coming from FastWave Medical! FastWave Medical has today announced successful 30-day results from the first-in-human study of its innovative system. The study aimed to assess the safety and feasibility of the IVL system in patients with peripheral arterial disease (PAD) affecting the superficial femoral and popliteal arteries with moderate to severe calcium. Key Highlights: ✅ 100% procedural success and 0% peri-procedural adverse events ⬇️ 5.9% mean residual diameter stenosis post-therapy 👏 At 30 days, 0% major adverse events, 100% patency, and 0% revascularization 📈 Patients recoded improved walking distance, speed, stair-climbing ability, and ankle-brachial index #IVL #intravascular #MedTech #medicaldevices

Transition From Transvenous to Subcutaneous to Extravascular #ICD: Nicole Mamprejew, MD, and colleagues present a case illustrating the importance of tailoring ICD selection to each patient. https://okt.to/ip75x2

Future need for coronary access is one important aspect when choosing which THV device to implant in patients planned for TAVI https://lnkd.in/dJDpFYCv

Transcatheter mitral valve (MV) implantation is a viable treatment option for elderly patients with mitral annular calcification (MAC) at prohibitive surgical risk. This CASE report demonstrates the use of a novel echocardiographic software as an alternative to contrast-enhanced CCT for preprocedural valve-in-MAC screening and outlines technical considerations aimed at mitigating the risk of left ventricular outflow tract obstruction (LVOTO).

A very comprehensive and thoughful figure from the 2024 ESC Guidelines for the managment of Chronic coronary syndrome, showing the safety, efficacy of combination of Antianginal vs Solo therapies. #ClinicalPharmacy #medical #Cardiology #PatientSafety #HealthCare.

A review of published literature on 324 procedures utilizing the CLEANER™ Rotational Thrombectomy System for AV graft and fistula thrombectomies reveals the total patency rate of over 96% and a complication rate of 0%. These results demonstrate how CLEANER can efficiently restore flow of AV accesses, allowing patients to return to dialysis treatments. https://lnkd.in/gF67XDSZ #KeepitCLEANER

Spectroscopy: The future of fast, accurate point-of-care diagnostics! Spectroscopy is setting new standards in POC diagnostics with its rapid, non-invasive, and precise analysis. Whether it’s glucose monitoring or critical blood perfusion systems, our portable solutions deliver real-time results and simplify sample collection. Explore how Avantes' innovative technology is enhancing patient care. #Healthcare #Spectroscopy #POCDiagnostics #Avantes

❤️ Emotional Case Report that was published in the European Society of Cardiology, European Heart Journal on 18 August 2023: "Clinical considerations during spontaneous coronary artery dissection in the post-partum period: a case report." ❤️ A case of a young women presenting with chest pain in the post-partum period. Her clinical appearance was that of a myocardial infarction, and angiography was indicative of a Type 2 SCAD. The patient had persistent chest pain, reduced left ventricular function, and critical left anterior descending artery stenosis. With a single long EluNIR™ ridaforolimus drug eluting stent (Medinol, Tel Aviv, Israel, 2.75 mm diameter × 28 mm length) with a good angio-graphic result and optimal distal angiographic flow. The patient had immediate clinical improvement and was transferred for observation in the coronary care unit. Thank you Nili Schamroth Pravda, Ohad Houri, Ran Kornowski, Avital Porter. https://lnkd.in/dg2pv8Mz #OCT #CoronaryArteryDisease #PCI #OCTImaging #ClinicalData #vascular #vascularsurgery #endovascular #vasculartips #cardiology #InterventionalCardiology #EndovascularTechniques #interventionalradiology #Radiology #Medicaldevices #Healthcare #stent #pci #medicaldevices #medical #hospitals #lifesciences #health #healthcare #healthcareindustry #medicaldevices #medicaldevice #medicaldevicemanufacturing #medicaldeviceindustry #medicalequipment #medicalequipments #Vascular #PatientCare #cardiology #cardiologist #cardiovascular #clinicaltrials #clinicalresearch

Patients with unexplained embolic strokes might have a right-to-left shunt (RLS) due to a patent foramen ovale (PFO). Studies show that closing a PFO can reduce stroke risk in select individuals. Tests like TTE, TEE, and TCD are vital, especially for young patients without typical stroke risk factors. Robot-assisted TCD (raTCD) is revolutionizing stroke workups by automating detection and enhancing sensitivity, even in community hospitals without specialized expertise. This innovation promises to make PFO screening more accessible, ensuring more patients get the right diagnosis and treatment to prevent future strokes. Read more: https://bit.ly/45WpZPC #StrokePrevention #MedicalInnovation #PFO #HealthcareTech